Brian M. Lingerfelt, MD
Medical Oncology and Hematology Specialist
Brian M. Lingerfelt, MD earned his undergraduate degree in Chemistry from Furman University in Greenville, South Carolina. He graduated from Virginia Commonwealth University School of Medicine at the Medical College of Virginia Campus in Richmond, Virginia, and continued his medical training with an internship and residency in Internal Medicine at Virginia Commonwealth University Health System. He completed his fellowship in Hematology and Medical Oncology at the Emory University Winship Cancer Institute in Atlanta, Georgia.
Dr. Lingerfelt performed extensive laboratory research at Furman University synthesizing anti-cancer drugs and at Virginia Commonwealth University Health System analyzing the effect of checkpoint kinase inhibitors in multiple myeloma cell lines. His clinical research at Emory University focused on the inflammatory response to tyrosine kinase inhibitors in kidney cancer.
He has published in the Journal of Supportive Oncology, the Journal of Pharmaceutical and Biomedical Analysis, and Bioorganic and Medicinal Chemistry. He is a member of the American Medical Association, the American Society of Clinical Oncology, and the American Society of Hematology. Dr. Lingerfelt joined Charleston Oncology, P.A., in 2012.
Choose your preferred location
West Ashley
North Charleston
Downtown
Summerville
Mt. Pleasant
Walterboro
Send UsA Message
The Importance of Subspecialization in Oncology: Our Commitment at Charleston Oncology
The Importance of Subspecialization in Oncology: Our Commitment at Charleston OncologyAt Charleston Oncology, we know that a cancer diagnosis can be overwhelming. For most patients, the search for the right doctor quickly becomes one of the most important steps on...
Lung Cancer in Non-Smokers: What You Should Know
Lung Cancer in Non-Smokers: What You Should KnowAt Charleston Oncology, we understand that lung cancer is often linked to smoking, but it’s important to remember that lung cancer can affect anyone, even those who have never smoked. As part of Lung Cancer Awareness...
Why Early Detection Matters: Breast Cancer Screening Guidelines By Age
Why Early Detection Matters: Breast Cancer Screening Guidelines By AgeBreast cancer is the most common cancer diagnosed in women, but it is also one of the most treatable when found early. Early detection is the single most powerful tool we have in the fight against...
Proactive Health: Prostate and Blood Cancer Awareness
Proactive Health: Prostate and Blood Cancer AwarenessTaking charge of your health means being informed and proactive, especially when it comes to cancer prevention and early detection. This September, as we observe both Prostate Cancer Awareness Month and Blood Cancer...
The Patients’ Unique Needs
From diagnosis to treatment and follow-ups, Charleston Oncology, as a part of the Department of Bon Secours St. Francis’ leading multidisciplinary cancer care team, plays a vital role in guiding patients through their breast cancer journey.
Landing on Your Feet: Celebrating Life After Cancer
From diagnosis to treatment and follow-ups, Charleston Oncology, as a part of the Department of Bon Secours St. Francis’ leading multidisciplinary cancer care team, plays a vital role in guiding patients through their breast cancer journey.